LONGEVITY with Nathalie Niddam Biostrap Part 2: Chief Science Officer Kevin Longoria talks about the Impact of Biostrap technology
In this episode, Part 2 of the Biostrap EVO series, we get the perspective of Biostrap's Chief Science Officer - Kevin Longoria on the Biostrap technology, some of the clinical studies using it and how to apply some of the metrics to your health journey.
Kevin and I continue the conversation about how the Biostrap EVO could be an essential tool for Biohackers looking for clinical grade data that they can trust. We go deeper into a new metric - arterial age and elasticity and how it may turn out to be a powerful way to assess and monitor cardiovascular health. This episode has a lot of great insights! Listen in.
Meet this week's guest:
Kevin Longoria is an expert in the field of Clinical Physiology with an emphasis on cardiopulmonary and nervous system-based approaches to optimizing health and athletic performance. His previous role is a Chief Science Officer (CSO) for a progressive neuroscience company. He is currently a Clinical Exercise Physiologist and the Chief Science Officer at Biostrap.
To buy a Biostrap: Biostrap.com
To save 10% use promo code Longevity10
Key Highlights:
01:51 How Kevin found the Biostrap and ultimately became their Chief Science Officer
03:34 Biostrap is adapting through generations
05:46 What are the limitations of Biostrap?
07:58 What are the reading specifications of Biostrap?
08:28 Understanding Arterial Age
10:20 The ideal metrics for humans
12:14 The Biostrap data checking process
15:42 The most important metrics for people
23:52 How meditation reflects data
27:13 Wearable technology and Covid research
29:16 Covid intervention
33:42 Biometrics trigger indicators
40:51 Ideal sleeping pattern routine
Linkage:
Patrick McCown's book, The Oxygen
Connect with Kevin:
Website: biostrap.com
Linkedin: https://www.linkedin.com/in/kevin-longoria-2b581b164/